Litigation Details for SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS, INC. (D.N.J. 2014)
✉ Email this page to a colleague
SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS, INC. (D.N.J. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-10-01 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-03-16 |
| Cause | 35:271 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Parties | ACTAVIS PHARMA, INC. | ||
| Patents | 8,298,580; 8,663,683; 8,877,248; 8,889,191; 8,992,989 | ||
| Attorneys | ELEONORE OFOSU-ANTWI | ||
| Firms | Paul Hastings LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SUPERNUS PHARMACEUTICALS, INC. v. ACTAVIS, INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-03-08 | 134 | 2016 regarding patent claims in Plaintiff’s U.S. Patent Nos. 8,298,580 (“the ’580 patent”), 8,663,683…8,663,683 (“the ’683 patent”), 8,877,248 (“the ’248 patent”), 8,889,191 (“the ’191 patent”), and 8,992,989…the ’683 Patent; (IV) infringement of the ’248 Patent; (V) infringement of the ’191 Patent; and (VI…of the patents in suit in this Opinion are made to that of the ’580 patent. Because the patents in suit… and 15 of the ’683 patent, claim 2 of the ’248 patent, claim 1 of the ’191 patent, and claim 2 of | External link to document | |
| 2017-03-16 | 192 | and counterclaims with respect to U.S. Patent Nos. 8,877,248 and 8,992,989, etc. Signed by Judge Susan…2014 16 March 2017 2:14-cv-06102 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
